You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKinsey
McKesson
Colorcon
Merck
Baxter

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074139

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

NDA 074139 describes CLOBETASOL PROPIONATE, which is a drug marketed by Glenmark Pharms Ltd, Ingenus Pharms Llc, Perrigo Israel, Perrigo Uk Finco, Taro, Aleor Dermaceuticals, Amneal Pharms Llc, Cosette, Fougera Pharms Inc, Glenmark Pharms, Lupin Ltd, Mylan, Rising, Teligent Pharma Inc, Teva Pharms Usa, Torrent, Xiromed, Zydus Pharms, Fougera Pharms, Perrigo Co, Actavis Mid Atlantic, Cadila, Hi Tech, Encube, Novel Labs Inc, Macleods Pharms Ltd, Saptalis Pharms, Tolmar, Wockhardt Bio Ag, Akorn, Apotex, and Paddock Llc, and is included in seventy-one NDAs. It is available from forty-five suppliers. Additional details are available on the CLOBETASOL PROPIONATE profile page.

The generic ingredient in CLOBETASOL PROPIONATE is clobetasol propionate. There are fourteen drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for 074139
Tradename:CLOBETASOL PROPIONATE
Applicant:Cosette
Ingredient:clobetasol propionate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 074139
Medical Subject Heading (MeSH) Categories for 074139
Suppliers and Packaging for NDA: 074139
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CLOBETASOL PROPIONATE clobetasol propionate CREAM;TOPICAL 074139 ANDA Actavis Pharma, Inc. 0472-0400 0472-0400-15 1 TUBE in 1 CARTON (0472-0400-15) > 15 g in 1 TUBE
CLOBETASOL PROPIONATE clobetasol propionate CREAM;TOPICAL 074139 ANDA Actavis Pharma, Inc. 0472-0400 0472-0400-30 1 TUBE in 1 CARTON (0472-0400-30) > 30 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:Aug 3, 1994TE:AB1RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Dow
Boehringer Ingelheim
AstraZeneca
Baxter
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.